These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 32670261
1. Distribution of de novo Donor-Specific Antibody Subclasses Quantified by Mass Spectrometry: High IgG3 Proportion Is Associated With Antibody-Mediated Rejection Occurrence and Severity. Pernin V, Beyze A, Szwarc I, Bec N, Salsac C, Perez-Garcia E, Mourad G, Merville P, Visentin J, Perrochia H, Larroque C, Couzi L, Le Quintrec M. Front Immunol; 2020; 11():919. PubMed ID: 32670261 [Abstract] [Full Text] [Related]
3. IgG3 donor-specific antibodies with a proinflammatory glycosylation profile may be associated with the risk of antibody-mediated rejection after kidney transplantation. Pernin V, Bec N, Beyze A, Bourgeois A, Szwarc I, Champion C, Chauvin A, Rene C, Mourad G, Merville P, Visentin J, Perrochia H, Couzi L, Larroque C, Le Quintrec M. Am J Transplant; 2022 Mar; 22(3):865-875. PubMed ID: 34863025 [Abstract] [Full Text] [Related]
4. Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure. Khovanova N, Daga S, Shaikhina T, Krishnan N, Jones J, Zehnder D, Mitchell D, Higgins R, Briggs D, Lowe D. Transpl Int; 2015 Dec; 28(12):1405-15. PubMed ID: 26264744 [Abstract] [Full Text] [Related]
5. IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury. Lefaucheur C, Viglietti D, Bentlejewski C, Duong van Huyen JP, Vernerey D, Aubert O, Verine J, Jouven X, Legendre C, Glotz D, Loupy A, Zeevi A. J Am Soc Nephrol; 2016 Jan; 27(1):293-304. PubMed ID: 26293822 [Abstract] [Full Text] [Related]
6. Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation. Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M. Transplantation; 2018 Apr; 102(4):688-698. PubMed ID: 29135832 [Abstract] [Full Text] [Related]
7. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study. Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA. Transplantation; 2017 Mar; 101(3):631-641. PubMed ID: 27120452 [Abstract] [Full Text] [Related]
8. Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes? Cicciarelli JC, Lemp NA, Chang Y, Koss M, Hacke K, Kasahara N, Burns KM, Min DI, Naraghi R, Shah T. J Immunol Res; 2017 Mar; 2017():1652931. PubMed ID: 28182088 [Abstract] [Full Text] [Related]
9. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients. Pongpirul W, Chancharoenthana W, Pongpirul K, Leelahavanichkul A, Kittikowit W, Jutivorakool K, Nonthasoot B, Avihingsanon Y, Eiam-Ong S, Praditpornsilpa K, Townamchai N. Nephrology (Carlton); 2018 Feb; 23(2):169-174. PubMed ID: 27888573 [Abstract] [Full Text] [Related]
10. Late Antibody-Mediated Rejection in a Large Prospective Cross-Sectional Study of Kidney Allograft Recipients--Preliminary Results of the Screening Phase of the BORTEJECT Trial. Eskandary F, Bond G, Regele H, Kozakowski N, Kikić Z, Wahrmann M, Haslacher H, Oberbauer R, Ramassar V, Halloran P, Böhmig GA. Clin Transpl; 2014 Feb; ():189-95. PubMed ID: 26281144 [Abstract] [Full Text] [Related]
11. Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies. Arnold ML, Ntokou IS, Doxiadis II, Spriewald BM, Boletis JN, Iniotaki AG. Transpl Int; 2014 Mar; 27(3):253-61. PubMed ID: 24118579 [Abstract] [Full Text] [Related]
12. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization. Vo AA, Sinha A, Haas M, Choi J, Mirocha J, Kahwaji J, Peng A, Villicana R, Jordan SC. Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792 [Abstract] [Full Text] [Related]
13. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study. Zhang H, Zheng C, Li X, Fu Q, Li J, Su Q, Zeng L, Liu Z, Wang J, Huang H, Xu B, Ye M, Liu L, Wang C. Front Immunol; 2020 Jul; 11():342. PubMed ID: 32184785 [Abstract] [Full Text] [Related]
14. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes. Freitas MC, Rebellato LM, Ozawa M, Nguyen A, Sasaki N, Everly M, Briley KP, Haisch CE, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI. Transplantation; 2013 May 15; 95(9):1113-9. PubMed ID: 23514959 [Abstract] [Full Text] [Related]
15. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation. Luque S, Lúcia M, Melilli E, Lefaucheur C, Crespo M, Loupy A, Bernal-Casas D, Gomà M, Jarque M, Crespo E, Montero N, Manonelles A, Cruzado JM, Gil-Vernet S, Grinyó JM, Bestard O. Am J Transplant; 2019 Feb 15; 19(2):368-380. PubMed ID: 30085394 [Abstract] [Full Text] [Related]
16. Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients. Aubert O, Loupy A, Hidalgo L, Duong van Huyen JP, Higgins S, Viglietti D, Jouven X, Glotz D, Legendre C, Lefaucheur C, Halloran PF. J Am Soc Nephrol; 2017 Jun 15; 28(6):1912-1923. PubMed ID: 28255002 [Abstract] [Full Text] [Related]
17. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure. Malheiro J, Santos S, Tafulo S, Dias L, Martins S, Fonseca I, Almeida M, Pedroso S, Beirão I, Castro-Henriques A, Cabrita A. Transplantation; 2018 Nov 15; 102(11):1943-1954. PubMed ID: 29757900 [Abstract] [Full Text] [Related]
18. Validation and cross-reactivity pattern assessment of monoclonal antibodies used for the screening of donor-specific IgG antibody subclasses in transplant recipients. Jucaud V, Nguyen A, Tran B, Hopfield J, Pham T. J Immunol Methods; 2020 Nov 15; 486():112847. PubMed ID: 32888965 [Abstract] [Full Text] [Related]
19. Intensity of de novo DSA detected by Immucor Lifecodes assay and C3d fixing antibodies are not predictive of subclinical ABMR after Kidney Transplantation. Bertrand D, Kaveri R, Laurent C, Gatault P, Jauréguy M, Garrouste C, Sayegh J, Bouvier N, Caillard S, Lanfranco L, Thierry A, François A, Hau F, Etienne I, Guerrot D, Farce F. PLoS One; 2021 Nov 15; 16(4):e0249934. PubMed ID: 33886604 [Abstract] [Full Text] [Related]
20. A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies. Halloran PF, Famulski KS, Chang J. Am J Transplant; 2017 Jan 15; 17(1):129-139. PubMed ID: 27340822 [Abstract] [Full Text] [Related] Page: [Next] [New Search]